1. Efficacy of alogliptin, a dipeptidyl peptidase‐4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE) – receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes. Issue 8 (November 2013) Authors: Sakata, Koji; Hayakawa, Manabu; Yano, Yuichiro; Tamaki, Noboru; Yokota, Naoto; Eto, Takuma; Watanabe, Reiko; Hirayama, Naoteru; Matsuo, Takeshi; Kuroki, Kazuo; Sagara, Seiji; Mishima, Osamu; Koga, Masahiro; Nagata, Naoto; Nishino, Yuri; Kitamura, Kazuo; Kario, Kazuomi; Takeuchi, Masayoshi; Yamagi... Journal: Diabetes/metabolism research and reviews Issue: Volume 29:Issue 8(2013:Nov.) Page Start: 624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MPS 10-03 Cognitive function according to ambulatory BP phenotypic measures in conjunction with office BP in elderly hypertensive patients. (September 2016) Authors: Hayakawa, Manabu; Yano, Yichiro Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes. (25th August 2015) Authors: Mizushige, Tomoko; Kobori, Hiroyuki; Nishijima, Yoko; Yano, Yuichiro; Sakata, Koji; Hayakawa, Manabu; Nishiyama, Akira Other Names: Larijani Bagher Academic Editor. Journal: Journal of diabetes research Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗